
Beyfortus (nirsevimab-alip) is a respiratory syncytial virus (RSV) F protein-directed fusion inhibitor indicated for the prevention of RSV lower respiratory tract disease in neonates and infants. This formulation is supplied as a 100 mg/mL solution in a 1 mL prefilled syringe, packaged 5 syringes per package.
Sorted by lowest price · Add now, sign in at checkout


Sorted by lowest price · Add now, sign in at checkout

Beyfortus (nirsevimab-alip) is a respiratory syncytial virus (RSV) F protein-directed fusion inhibitor indicated for the prevention of RSV lower respiratory tract disease in neonates and infants. This formulation is supplied as a 100 mg/mL solution in a 1 mL prefilled syringe, packaged 5 syringes per package.
1 vendor
Products you might be interested in